Y-mAbs Therapeutics, Inc.

BNP PARIBAS FINANCIAL MARKETS

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

94,383

Value ($000)

426

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	426	0.0%	94,383	6/30/2025
2025 Q1	5/14/2025	423	0.0%	95,502	3/31/2025
2024 Q4	2/14/2025	38	0.0%	4,874	12/31/2024
2024 Q3	11/13/2024	347	0.0%	26,419	9/30/2024
2024 Q2	8/13/2024	326	0.0%	26,956	6/30/2024
2024 Q1	5/1/2024	567	0.0%	34,875	3/31/2024
2023 Q4	2/14/2024	240	0.0%	35,174	12/31/2023
2023 Q3	11/14/2023	74	0.0%	13,493	9/30/2023
2023 Q2	8/9/2023	65	0.0%	9,597	6/30/2023
2023 Q1	5/12/2023	178	0.0%	35,504	3/31/2023
2022 Q4	2/14/2023	168	0.0%	34,396	12/31/2022
2022 Q3	11/16/2022	563	0.0%	39,011	9/30/2022
2022 Q2	8/12/2022	121	0.0%	7,980	6/30/2022
2022 Q1	5/18/2022	35	0.0%	2,928	3/31/2022
2021 Q4	2/9/2022	148	0.0%	9,100	12/31/2021
2021 Q3	11/16/2021	184	0.0%	6,449	9/30/2021
2021 Q2	8/10/2021	52	0.0%	1,528	6/30/2021
2021 Q1	5/7/2021	310	0.0%	10,265	3/31/2021
2020 Q4	2/10/2021	3,362	0.0%	67,905	12/31/2020
2020 Q3	10/30/2020	271	0.0%	7,049	9/30/2020
2020 Q2	8/6/2020	92	0.0%	2,137	6/30/2020
2020 Q1	5/13/2020	270	0.0%	10,335	3/31/2020
2019 Q4	2/12/2020	86	0.0%	2,744	12/31/2019